Current guidelines, challenges and future recommendations for regulation of stem cell research and therapy: a commentary.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 38775774.
- Also identified by DOI 10.1016/j.jcyt.2024.04.076.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In recent years, Malaysia has seen a surge in stem cell therapy for various medical conditions. However, the regulation of stem cell research and therapy in Malaysia faces several challenges such as the emergence of unregulated clinics and a lack of specific legislation. Some urgent measures, including enactment of specific laws, strengthened monitoring, as well as increased public awareness and education, are crucial. Therefore, stem cell therapy regulation requires concerted efforts by the policymakers, regulator bodies and healthcare professionals. This commentary discusses the current guidelines and challenges in Malaysian stem cell therapy regulation and proposes some future recommendations that could pave the way for responsible progress of stem cell research and therapy globally.
Medical subject headings
- Stem Cell Research
- Stem Cell Transplantation